Azenta Inc (FRA:BA3)
€ 43.6 -1 (-2.24%) Market Cap: 1.99 Bil Enterprise Value: 1.61 Bil PE Ratio: 0 PB Ratio: 1.19 GF Score: 69/100

Azenta Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 03:30PM GMT
Release Date Price: €58
Zachary Conte

Hello, everyone. Good morning. Thank you for coming. My name is Zach Conte. I'm a member of the health care investment banking team here at JPMorgan. It's my pleasure to introduce Azenta Life Sciences. Today, we're joined by Stephen Schwartz, CEO. There will be a presentation followed by a short Q&A. Thank you.

Stephen S. Schwartz
Azenta, Inc. - CEO, President & Director

Thank you, Zach. Good morning, everyone. It's great to see you here. Just let me start. We're delighted to have a chance, again, to present here at the JPMorgan Healthcare Conference. I'm proud to represent about 4,000 employees worldwide from Azenta who are really focused on delivering on our purpose to enable breakthroughs faster. I'd love to convey just a short summary of where we are as a company, catch up a little bit from the report we had last quarter and also talk about the future as we see it. Toward that end, I will be making forward-looking statements. I just want to remind everyone, call your attention to our safe harbor statement at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot